Follow the Enzymatica AB (publ) stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Enzymatica AB (publ) has recorded 8 insider filings. Market capitalisation: €447.8m. The latest transaction was filed on 20 July 2026 (Purchase). Among the most active insiders: Anna Söderlund. All data is openly available.
8
Insider Decl.
n/a
Thresholds
€120,924
7 ops.
Buy Volume
€10,959
1 ops.
Sell Volume
32Σ signal
Buys €120,924€10,959 Sells
Fundamental score
Ranked 25,706 of 28,803 companies
22.7
score / 100
Value
16
Quality
30
FCF yld-9.1%
Earn yld-11%
EV/EBITDA·
ROE-38%
Gross mgn61%
Net mgn-96%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
100,000 shares@ €0.24040.0040% mcap64.0% of flowAktieISINISIN SE0003943620FI:A003M153-1
8 of 8 declarations
About Enzymatica AB (publ)
Enzymatica AB (publ) is a Swedish company focused on the development of health and pharmaceutical products. It is listed on the Stockholm Stock Exchange (XSTO).